Metronidazole uptake in Helicobacter pylori

Can J Microbiol. 1995 Aug;41(8):746-9. doi: 10.1139/m95-102.

Abstract

Currently, the mechanism of metronidazole resistance is not understood in Helicobacter pylori. We have looked at uptake of metronidazole into a sensitive and a resistant strain of H. pylori. Both strains displayed rapid uptake of [14C]metronidazole, although the resistant strain accumulated the drug at a slower rate and to a lesser amount than the sensitive strain. Uptake was inhibited by KCN and carbonyl cyanide m-chlorophenyl-hydrazone (CCCP) but not by sodium arsenate. Thin-layer chromatography analysis of lysed cell supernatants showed that metronidazole was metabolized in both strains. A variety of related imidazole compounds inhibited metronidazole uptake, consistent with a common transport system for this group of antibiotics. Our data do not support an absence of uptake or metabolism as a cause of resistance in the strain examined.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Biological Transport, Active / drug effects
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone / pharmacology
  • Drug Resistance, Microbial
  • Helicobacter Infections / drug therapy
  • Helicobacter pylori / drug effects
  • Helicobacter pylori / isolation & purification
  • Helicobacter pylori / metabolism*
  • Humans
  • Imidazoles / pharmacology
  • Kinetics
  • Metronidazole / pharmacokinetics*
  • Metronidazole / pharmacology
  • Potassium Cyanide / pharmacology

Substances

  • Imidazoles
  • Metronidazole
  • Carbonyl Cyanide m-Chlorophenyl Hydrazone
  • Potassium Cyanide